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The aim of this study was to determine the effect of lipid 
ratio of stearic acid and oleic acid on the physical characteristics 
as well as the entrapment efficiency of diethylammonium 
diclofenac with Nanostructure Lipid Carrier (NLC) system. 
Diethylammonium diclofenac (DETA) is Non-Steroid Anti-
Inflamatory Drugs (NSAIDs) that has been widely used in the 
treatment of osteoarthritis and rheumatoid arthritis. In the 
formulation of NLC-DETA, three different lipid ratios were used, 
which the ratio of  stearic acid:oleic acid were 60:40, 70:30, and 
80:20, respectively. In this NLC system, DETA served as the 
active drug, stearic acid as solid lipid, oleic acid as liquid lipid, 
and Tween 80 as surfactant components. NLC were characterized 
for organoleptic characteristics, pH, viscosity, particle 
morphology, particle size and polydispersity index (PI), profiles 
of Fourier Transform Infra-Red (FTIR) and Differential Thermal 
Analysis (DTA), and drug entrapment efficiency. The particle 
shape and morphology were determined by Transmission 
Electron Microscopy (TEM). The results  showed that the different 
ratios of oleic acid lipids and stearic acid had no significant 
effects on the viscosity and entrapment efficiency of NLC-DETA. 
On the other hand, it affected the pH of all formulas, which were 
significantly different. Increasing the amount of liquid lipid in the 
formulations reduced the size of NLC-DETA particles.   
  




Non-Steroid Anti-Inflamatory Drugs 
(NSAIDs) can be classified based on the drug’s 
selectivity to inhibit cyclooxygenase (COX) 
enzymes. This inhibition can reduce the 
synthesis of prostaglandins that leads to 
decrease of gastric mucosa production and 
triggers irritation (Gunawan et al., 2007). 
Diethylammonium diclofenac (DETA) is a 
non-selective COX inhibitor NSAID. In the 
oral route, the absorption of diclofenac in the 
intestines is fast and complete, but the 
bioavailability is only about 50% due to first-
pass metabolism effects. Approximately 99% of 
diclofenac is bound to plasma phenomena 
(Sweetman, 2009). According to these, it is 
important to prepare DETA into topical 
dosage forms. The topical route can improve 
the drug efficacy and patient compliance 
because it is more comfortable to use and may 
not available for first pass metabolism (Jorge et 
al., 2011). DETA is a lipophilic drug with log P 
value of 0.853, so it can be used for topical 
route. The ion pair formation between anions 
and cations of alkilamonium diclofenac may 
increase skin permeability and drug solubility in 
non-aqueous carrier (Fini et al., 2012). An 
analgesic such as DETA is intended to give 
rapid and long term effect. Therefore, it 
requires a delivery system that is capable of 
carrying DETA in order to achieve the desired 
effect. Nanostructure Lipid Carrier (NLC) may 
become an appropriate delivery system for 
DETA. NLC is a nano-sized particles which 
the drugs are dispersed in a binary mixtures of 
solid lipid and liquid lipid. The nanostructures 
of NLC can increase the drug loading capacity 
(Meghana et al., 2012). NLC provides many 
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advantages i.e. having low toxicity and 
increasing drug contact with the stratum 
corneum thus improving drug penetration 
because of its small particle size (Okyar et al., 
2012). NLC consists of a mixture of solid lipid 
and liquid lipid that can accommodate the 
space needed for the entrapping drugs 
(Meghana et al., 2012). NLC components of the 
system including the solid lipid and liquid lipid. 
The efficacy of this carrier system is highly 
determined by drug entrapment efficiency, 
which is affected by the ratio of the solid lipid 
and liquid lipid and particle size (Meghana et al., 
2012; Shinde et al., 2013). It has been reported 
that the NLC system of Q10 co-enzyme, which 
composed of cetyl palmitate-alpha tocopherol 
acetate at ratio of 70:30 (W/W), was produced 
in good characteristics of Q10 co-enzyme-
loaded NLC with high drug entrapment, good 
penetration, controlled-drug release, and stable, 
even for 90 days storage (Putranti et al., 2017). 
Other study reported that the meloxicam-
loaded NLC (MLX) was used for topical 
application using monostearin and                  
alpha-tocopherol as lipid matrix. These              
lipids was combined at six different ratios of 
solid and liquid lipid matrix, which were 70:30, 
75:25, 80:20, 85:15, 90:10, and 95:5, 
respectively. Increasing the concentration of 
liquid  lipid in this NLC system enhanced the 
entrapment efficiency of MLX (Anggraeni et al., 
2017). 
This study aimed to investigate the 
characterization and entrapment efficiency of 
NLC loading DETA (DETA-NLC) prepared at 
different ratio of stearic acid and oleic acid.    
In addition, we further evaluated which lipid 
ratio that was able to produce good 
characterization and entrapment efficiency of 
DETA-NLC. 
 
MATERIALS AND METHODS 
DETA was obtained from PT. 
Combiphar. Stearic acid was bought from           
PT. Sumi Asih Oleochemicals Industry.          
The oleic acid was purchased from Marks              
& Nos Inc. Tween 80 was found from PT. 
Croda. All of these chemicals were in 
pharmaceutical grade. The Na2HPO4.2H2O and 
NaH2PO4.H2O were in analytical grade and 
bought from Merck. 
 
Preparation of diethylammonium 
diclofenac loaded NLC 
Firstly, the oleic acid, stearic acid, and 
DETA were put in a beaker glass and melt 
using a hot plate (Dragon Lab MS-H Pro) at 
75°C. On the other side, a beaker glass 
containing aqueous phase i.e. phosphate buffer 
and Tween 80 was stirred by heating at 80°C. 
This hot aqueous phase was then added into 
lipid phase and this mixture was then 
homogenized by using a high speed 
homogenizer (Ultra Turax High Shear 
Homogenizer) at speed of 3800rpm for 30min in 
3 cycles. The DETA-NLC was obtained by 
cooling the mixture at room temperature while 
stirring at 1500rpm for 30min.  
 
Characterization of deta-NLC  
Before characterization of DETA-NLC, 
the homogeneity test of each formula was 
evaluated by determining the recovery 
percentage, which was then calculated for the 
percentage of variation coefficient (%KV). It 
has been stated that homogenous preparation 
or formula was produced if the % KV value is 
less than 6%.  
 
pH 
The pH of DETA-NLC was measured 
with a digital pH meter (Schott Glass Mainz tipe 
CG 824), which was standardized using pH 6.0 
standard buffers before use.The electrode was 
inserted into about 10mL of DETA-NLC 
sample; the electrode must be sinked into 
sample. The pH values observed until the 
screen showed a stable results. 
 
Viscosity 
The viscosity of samples were measured 
using Brookfield Cone and Plate viscometer 
HDV-Y + CP. The cone was set at speed of 
20rpm and about 2.0mL of DETA-NLC sample 
was placed in the sample cup. The viscometer 
was then turned on and put down until the 
stable measurement result was achieved. 
 
Transmission electrone microscopy 
The particle morphology was determined 
by using Transmission Electron Microscopy 
(TEM JEOL JEM 1400). A drop of sample was 
placed on the grid, then it was stained with         
2% (w/v)   of   phosphotungstic acid   solution. 
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After staining process, the samples were          
dried at room temperature. Once the samples 
were ready, then they were observed with 
TEM. 
 
Measurement of particle size and 
Polydispersity Index (PDI) 
The analysis was performed at 25°C  
with detection angle of 165°C using a dynamic 
light scattering instrument (DelsaTM Nano 
Submicron Particle Size and Zeta Potential 
Dynamic Light Scattering). The particle size 
was calculated from the fluctuation of the 
average intensity of light scattering. The PDI 
shows the homogenity of particle size within 
nanoparticles population. 
 
Differential thermal analysis 
The thermal Analysis of stearic acid, 
DETA, and DETA-NLC were perfomed using 
Differential Thermal Analyzer (DTA SP 900 
Thermal System Metler Toledo SP 85). All the 
samples were heated in aluminum pans. The 
analysis was performed with a heating range of 
30-200°C and at a hating rate of 5°C/min. 
 
FTIR Spectroscopy 
The FT-IR analysis helps to confirm the 
identity of the drug and to detect the 
interaction between the drug and carriers. The 
FT-IR spectral instrument (IR JASCO FT/IR-
5300 Instrument) was used for measurement of 
native DETA, single component of NLC, and 
DETA-NLC. The samples were analyzed at 
ambient temperature. All the spectra acquired 
were scanned between 400 and 4000cm-1 
 
The drug quantification assay and 
entrapment efficiency 
About 0.1g of DETA-NLC was 
dissolved in a 10mL of phosphate buffer pH 
6.0±0.1. This mixture was then centrifuged 
(Hettich Rotofix 32) at 2500rpm for 30min, 
and then filtered through 0.45μm filter paper     
to obtain free drug that contained in                      
the supernatant. The concentration of DETA 
in the supernatant was then determined by  
UV-VIS spectrophotometer (Double beam 
Spectrophotometer UV-1800 Shimadzu) using 
three wavelength methods, which were 266nm, 
276nm, and 286nm with appropriate dilutions. 
The Entrapment efficiency was calculated using 
following equation. 
 
% EE = 
Wa – Ws 
  100% 
Wa 
 
which EE refers to entrapment efficiency, Wa 
stands for the weight amount of DETA added 
to the formulation, and Ws is the quantified 
weight of DETA in the supernatant. 
 
Statistical analysis 
The characterization of DETA-NLC 
system, which includes pH, viscosity, particle 
size, and entrapment efficiency of drug, was 
statistically analyzed using a one-way analysis of 
variance (ANOVA) method at a 95% 
confidence interval. Then, the results were 
further analyzed using honestly significant 
difference (HSD) test. 
 
RESULT AND DISCUSSION 
Preparation of  NLC diethylammonium 
diclofenac 
It has been known that the melt 
emulsification followed by high speed 
homogenization is a reliable, simple and 
reproducible method for preparation of NLC. 
In this study, the high speed homogenization of 
the lipid phase with hot aqueous phase 
containing surfactant such as Tween 80 at 
speed of 3800rpm for 10min was sufficient to 
produce an emulsion with average particle size 
between 351.9-1370.0nm. The homogeneity 
test results showed that the DETA recovery 
Table I. Composition of the DETA-NLC formulations (% w/w) 
 
Composition  Formula 1 (F1) Formula 2 (F2) Formula 3 (F3) 
DETA 1.16  1.16 1.16 
Stearic acid 6 7 8 
Oleic acid 4 3 2 
Tween 80 5 5 5 
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percentage of F1, F2, and F3 of DETA-NLC 
were 107.2%, 106.9%, and 106.3%, 
respectively.  Moreover, the percentage of KV 
of F1, F2 and F3 were 3.35%, 0.97%, and 
1.46%, respectively (Table I).  
pH 
The pH of the all formula was found 
about 6.157 to 6.326 (Table II). It could be 
suggested that DETA-NLC can be used for 
topical application without producing skin 
irritation. Based on the statistical analysis of 
ANOVA followed by HSD test, the results 
showed that there were significant difference of 
pH values among all formula, which were 
F1<F2<F3. These differences may be due to 
the different amount of oleic acid used in NLC. 




The viscosity of the sample is intended 
to enable NLC adhering onto the skin surface, 
thus increasing the residence time and drug 
penetration across the skin. Thereby, it can 
improve drug availability at site of action by a 
controlled-manner and avoid systemic 
absorption. As (Table II), the results showed 
no significance differences of viscosities  
among all formulas (P>0.05). It indicates that 
different ratio of stearic acid and oleic acid 
produced no effects on the viscosity of the 
DETA-NLC.  
 
Transmission electrone microscopy 
The particle morphology of NLC was 
evaluated with JEOL JEM 1400 TEM electron 
microscope at a magnification of 80.000times. 
The photomicrograph showed that there were 
spherical forms observed that corresponds to 
NLC particles (Figure 1). The observed particle 
size was less than 100nm. However, the NLC 
particles of F1 and F2were seen separately and 
not clustered. While on the F3, they attached 
each other. 
 
Particle size and PDI 
The optimized NLC formula showed 
small particle size and the value of 
polydispersity index (PDI) of all formula were 
found to be <1.0µm. It suggested that the 
optimized NLC formula have particle size in 
nanometer range and monodispered system, 
which remains stable and will not convert 
macrometer range particles. As the result, F1 
showed the smallest particle size. On the other 
hand, F3 had a micrometer size that may 
Table II. The pH and viscosity of DETA-NLC  
 
Formula pH Viscosity (cps) 
F1 (60:40) 6.157±0.010 226.7±115.9 
F2 (70:30) 6.219±0.008 288.8±73.4 




Figure 1. Transmission electron photomicrograph of F1(60:40, Formula 1), F2 (70:30, Formula 2), 
and F3 (80:20, Formula 3) of DETA-NLC at magnification of 80000 X.  
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because of the low amount of oleic acid. The 
greater amount of liquid lipid, the smaller the 
particle size of the NLC could be achieved. At 
a ratio of stearic acid and oleic acid of 80:20, 
respectively, it would require large amounts 
surfactants to stabilize the system and prevent 
aggregation of lipid particles. In this study, the 
particle size that was measured by TEM was 
smaller than that of measured by DLS. It may 
be due to the effect of the dilution process 
during particle size measurement using DLS. 
PDI reflects the particle homogeneity and it 
varies from 0.0 to 1.0. The closer the value of 
PDI to 0, the more homogenous the particles. 
Increasing the solid lipid has been reported to 
cause the particle aggregation (Phatak and 
Chaudhari, 2013). F1 and F2 met the 
characteristics of the NLC system, which had 
sizes in nanometer range (<1μm) (Table III). 
While the F3 did not met the specification 
because of its micrometer size (>1μm). It might 
be due to the high amount of stearic acid and 
low amount of oleic acid of F3. At the ratio of 
stearic acid and oleic acid of 80:20, respectively, 
it requires a high amount of surfactant to 
stabilize the system and prevent the 
incorporation or aggregation of lipid particles. 
The surfactant was used to stabilize the 
nanoparticles and prevent the incorporation of 
particles (Pezeshki et al., 2014). To decrease the 
particle size of F3, a cosurfactant could be 
added as the system stabilizer, for preventing 
aggregation of lipid particles 
 
Table III. The particle size and Poly Dispersity 
Index(PDI) of DETA-NLC 
 
Formula Particle Size (nm) PDI 
F1 (60:40) 351.9±34.8 0.373±0.039 
F2 (70:30) 518.1±92.3 0.412±0.030 
F3 (80:20) 1370.0±326.5 0.489±0.032 
 
Based on one-way ANOVA analysis, 
there was significant difference of particle size 
of DETA-NLC (P=0.002). It was further 
analyzed using HSD test and the results 
showed that F1 (60:40) had particle sizes 
diameter that were similar to F2 (70:30).  On 
the other hand, F3 (80:20) had significantly 
different particle size compared to F1 and F2. 
Moreover, the results of TEM analysis 
supported these results. F3 showed the largest 
particle size and PDI among the three 
formulas. It could be suggested that the lipid 
particles of F3 have a tendency to aggregate. 
Therefore, the particles would easily attach each 
other forming large sized-particles. It was 
confirmed by the high PDI value of F3, which 
represented the non-homogeneous size 
distribution of F3 NLC particles. 
 
Differential Thermal Analysis (DTA) 
DTA was performed to determine the 
melting point of NLC-DETA and its 
components. In this study, native DETA has a 
melting point of 155.3oC (Figure 2). After it 
was prepared into NLC-DETA, DETA peak 
did not appear on the entire formula. The 
shifting peak of DETA showed that it has been 
trapped inside the NLC system. There was a 
large peak seen in the all the formula, which 
was within 110-114°C. Due to the interaction 
among the NLC components, it might produce  
the polymorphism of stearic acid. It could be 
triggered by the addition of about 1-5% 





Figure 2. The profiles of differential thermal 
analysis of DETA (A), stearic acid (B), F1 




The FT-IR spectroscopy was carried out 
to evaluate the compatibility between native 
DETA with stearic acid, oleic acid, and Tween 
80 that have been used to prepare the NLC. 
The native DETA had characteristic IR peaks 
at 3588.27cm-1 (N-H); 744.26cm-1 (C-Cl); 
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1689.47cm-1 (C=C); 2992.25cm-1 (C-H sp3). 
(Figure 3E, F, and G) There were no differences 
in the absorption. It indicates that the different 
ratio of stearic acid and oleic acid used in these 
three NLC formulas did not produce any 
changes on their chemical structures and there 
was no chemical interaction between DETA 




Figure 3 The profiles of IR spectra of DETA 
(A), Stearic Acid (B),  Oleic Acid (C),  Tween 
80 (D), F1 (E), F2 (F), and F3 (G) of DETA-
NLC in wave numbers 400-4000cm-1. 
 
Entrapment efficiency 
The results indicate that the lipid 
concentration had critical effects on the 
entrapment efficacy of DETA. It has been 
known that the drug entrapment efficiency is 
lower for the sample with lower lipid 
concentration. The values of drug entrapment 
efficiency (Table IV). A higher concentration             
of liquid lipid resulted in larger particle size  
that would affect the amount of DETA 
entrapped inside of NLC. It is because the 
higher amount of liquid lipid was available           
to dissolve more drug molecules at formula 
with high lipid concentration. In addition the 
DETA entrapment is also affected by the 
solubility   of   DETA  in  the lipid component. 
DETA has good solubility in oleic acid, which 
was about 413.33±21.27mg/mL oleic acid. The 
high solubility of drugs in liquid lipids and solid 
lipids can improve the efficiency of the 
entrapment. (Hussain Shah et al, 2012; Patel et 
al., 2012). The statistical analysis showed that 
there was no significant difference between the 
formulas of NLC system. 
Table IV. The entrapment efficiency of DETA 
of DETA-NLC 
 
Formula EE (%) 
F1 (60:40) 73.858 ± 0.840 
F2 (70:30) 73.654 ± 2.079 
F3 (80:20) 73.172  ± 1.488 
 
CONCLUSION 
In this study, it can be concluded that 
the different ratios of oleic acid and stearic acid, 
which were 60:40, 70:30, 80:20, respectively, 
did not affect the sample viscosity. However, 
there was significantly different in the pH value 
of samples for all formulas. For samples 
particle size and PDI, the differences were 
occurred for formula with lipid ratio of 80:20 to 
60:40 and 70:30.  The differences of 




The authors thank to Faculty of 
Pharmacy Airlangga University  for support 
during this study.  
 
REFERENCES 
Anggraeni, Y., Haryanto, IY., Hendradi, E., 
2017. Physical and chemical 
characteristics of meloxicam from 
nanostructured lipid carriers system 
using some concentration ratios of 
monostearin and alpha-tocopherol 
acetate lipid matrix.  Asian J Pharm Clin 
Res, Vol 10, Issue 2, 2017, 132-137 
Fini, A., Bassini, G., Monastero, A., Cavallari, 
C., 2012. Diclofenac Salts, VIII. Effect 
of the Counterions on the Permeation 
through Porcine Membrane from 
Aqueous Saturated Solutions. J 
Pharmaceutics, Vol. 4, p. 413-429. 
Gunawan, SG., Setiabudy, R., Nafrialdi, & 
Elysabeth., 2007. Farmakologi dan 
Terapi, Edisi 5, Jakarta: Balai Penerbit 
FKUI, hal 230-233. 
Hussain Shah, SN., Salman, M., Ahmad, M., 
2012. Effect of Oleic Acid on the 
Permeation Kinetics of Diclofenac 
Diethylamine. J Chem Soc Pak, No.1, Vol. 
34 
Jorge, LL., Feres, CC., Vitor, EP., 2010. Topical 
Preparations for Pain Relief: Efficacy 
Effect of Lipid Ratio of Stearic Acid and Oleic Acid 
204   Volume 28 Issue 4 (2017) 
and Patient Adherence. J Pain Res, Vol. 4, 
p. 11-24. 
Meghana, SK., Vaidya, KK., Bhosale, AV., 
Chaundari, PD., 2012. Solid Lipid 
Nanoparticles and Nano Structure 
Carriers : An Overview. Int J Pharm Chem 
Bio Scie. Vol. 2(4), p. 681-691. 
Okyar, A., Özsoy, Y., Güngör, S., 2012. Novel 
Formulation Approaches for Dermal 
and Transdermal Delivery of Non-
Steroidal Anti-Inflamatory Drugs. Intech 
Open Scince Mind. 
Patel,   D.,   Dasgupta,   S.,   Dey,   S.,   
Ramani,   Y.   R.,   2012. Nano-
structured Lipid Carriers (NLC)-Based 
Gel for the Topical Delivery of 
Aceclofenac: Preparation, Charac-
terization, and In Vivo Evaluation. 
Scientia Pharmaceutica, p. 749-764. 
Phatak, AA. Chaudari, PD., 2013. Development 
and evaluation of nanostructured Lipid 
Carrier (NLC) Based Topical Delivery of 
an Anti-Inflammatory Drug. J Pharm Res, 
p. 677-685 
Putranti, AR., primaharinastiti, R., Hendradi, 
E., 2017. Effectivity and physicochemical 
stability of nanostructured lipid carrier 
coenzyme Q10 in different ratio of lipid 
cetyl palmitate and alpha tocopheryl 
acetate as carrier. Asian J Pharm Clinical 
Res, Vol 10, Issue 2, 2017, 1-7. 
Shinde, G., Rajesh, KS., Prajapati, N., Murthy, 
RSR., 2013. Formulation, Development 
and Characterization of Nanostructured 
Lipid Carrier (NLC) Loaded Gel for 
Psoriasis. Scholar Research Library, p. 13-
25. 
Sweetman, SC., 2009. Martindale The Complete 
Drug Reference, 36th ed., London : 
Pharmaceutical Press (PhP), p. 17, 44-47, 59.  
 
